Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis

Research in Immunology

Volumn 149, Issue 9, 1998, Pages

  Hjelmstrom P ^a   Juedes, A E ^a   Ruddle, N H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM; DEMYELINATION; DISEASE COURSE; DISEASE PREDISPOSITION; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NONHUMAN; PRIORITY JOURNAL; RAT; REMISSION; REVIEW; WEIGHT REDUCTION;

EID: 0032209147     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(99)80007-8     Document Type: Article

References (81)

1. Akassoglou, K., Probert, L., Kontogeorgos, G. & Kollias, G. (1997), Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol., 158, 438-445.
2. Balasa, B., Deng, C., Lee, J., Bradley, L.M., Dalton, D., Christadoss, P. & Sarvetnick, N. (1997), IFN-γ is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J. Exp. Med., 186, 385-391.
3. Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G. & Janeway, C.A. Jr, (1993), Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med., 177, 57-68
4. Barten, D.M. & Ruddle, N.H. (1994), Vascular cell adhesion molecule-1 modulation by TNF in experimental allergic encephalomyeleits. J. Neuroimmunol., 51, 123-133.
5. Barton, B.E. (1997), IL-6: Insights into novel biological activities. Clin. Immunol. Immunopathol., 85, 16-20.
6. Bernard, C.C.A., Johns, T.G., Slavin, A., Ichikawa, M., Ewing, C., Liu, J. & Bettadapura, J. (1997), Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med., 75, 77-88.
7. Billiau, A., Heremans, H.F.V., Dijkmans, R., Sobis, H., Meulepas, E. & Carton, H. (1988), Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ, J. Immunol., 140, 1506-1510.
8. Biswas, P., Delfanti, F., Bernasconi, S., Mengozzi, M., Cota, M., Polentarutti, N., Mantovani, A., Lazzarin, A., Sozzani, S. & Poli, G. (1998), Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood, 918, 256-265.
9. Brunner, C., Lassmann, H., Waehneldt, T.V., Matthieu, J.M. & Linington, C. (1989), Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J. Neurochem., 52, 296-304.
10. Calvo, C.F., Yoshimura, T., Gelman, M. & Mallat, M. (1996), Production of monocyte chemotactic protein-1 by rat brain macrophages. Eur. J. Neurosci., 8, 1725-1734
11. Campbell, I.L., Abraham, C.R., Masliah, E., Kemper, P., Inglis, J.D., Oldstone, M.B.A. & Mucke, L. (1993), Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci., USA, 90, 10061-10065.
12. Campbell, I.L. (1995), Neuropathogenic actions of cytokines assessed in transgenic mice. Int. J. Devl. Neurosci., 13, 275-284.
13. Chiang, C.-S., Stalder, A.K., Samimi, A. & Campbell, I.L. (1994), Reactive gliosis as a consequence of interteukin-6 expression in the brain. Studies in transgenic mice. Dev. Neurosci., 16, 212-221.
14. Chiang, C.S., Powell, H.C., Gold, L.H., Samimi, A. & Campbell, I.L. (1996), Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J. Clin. Invest., 97, 1512-1524.
15. Dahlman, I., Lorentzen, J.C., de Graaf, K.L., Stefferl, A., Linington, C., Luthman, H. & Olsson, T. (1998), Quantitative trait loci disposing for both experimental arthritis and encephalomyelitis in the DA rat; impact on severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis and antibody isotype pattern. Eur. J. Immunol., 28, 2188-2196.
16. Dedhia, V., Goluszko, E., Wu, B., Deng, C. & Christadoss, P. (1998), Defect of B cell-deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis. Clin. Immunol. Immunopathol., 87, 266-275.
17. De Togni, P., Goellner, J., Ruddle, N.H., Streeter, P.R., Fick, A., Mariathasan, S., Smith, S.C., Carlson, R., Shornick, L.P., Strauss-Schoenberger, J., Russel, J.H., Karr, R. & Chaplin, D. (1994) Abnormal development of periperhal lymphoid organs in mice deficient in lymphotoxin. Science, 264, 703-706.
18. Duong, T.T., St Louis, J., Gilbert, J.J., Finkelman, F.D. & Strejan, G.H. (1992), Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol., 36, 105-115.
19. Encinas, J.A., Weiner, H.L. & Kuchroo, V.K. (1996), Inheritance of susceptibility to experimental autoimmune encephalomyelitis. J. Neurosci. Res., 45, 655-669.
20. Eugster, H.-P., Frei, K., Kopf, M., Lassmann, H. & Fontana, A. (1998), IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol., 28, 2178-2187.
21. Falcone, M., Rajan, A.J., Bloom, B.R. & Brosnan, C.F. (1998), A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J. Immunol., 160, 4822-4830.
22. Fattori, E., Lazzaro, D., Musiani, P., Modesti, A., Alonzi, A. & Ciliberto, G. (1995), IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neural damage. Eur. J. Neurosci., 7, 2441-2449.
23. Ferber, I.A., Brocke, S., Taylor-Edwards, C., Ridgeway, W., Dinisco, C., Steinman, L., Dalton, D. & Fathman, C.G. (1996), Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol., 156, 5-7.
24. Frei, K., Eugster, H.-P., Bopst, M., Constantinescu, C.S., Lavi, E. & Fontana, A. (1997), Tumor necrosis factor a and lymphotoxin a are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med., 185, 2177-2182.
25. Gardinier, M.V., Amiguet, P., Linington, C. & Matthieu, J.M. (1992), Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J. Neurosci. Res., 33, 177-187.
26. Gausas, J., Paterson, P.Y., Day, E.D. & Dal Canto, M.C. (1982), Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats. Cell. Immunol., 72, 360-366.
27. Genain, C.P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D.P., Linington, C., Raine, C.S. & Hauser, S.L. (1996), Late complications of immune deviation therapy in a nonhuman primate. Science, 274, 2054-2057.
28. Genain, C.P., Nguyen, M.H., Letvin, N.L., Pearl, R., Davis, R.L., Adelman, M., Lees, M.B., Linington, C. & Hauser, S.L. (1995), Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest., 96, 2966-2974.
29. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W. & Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science, 268, 1766-1769.
30. Hartner, A., Goppelt-Struebe, M., Hocke, G.M. & Sterzel, R.B. (1997), Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6, and oncostatin M. Kidney Int., 51, 1754-1760.
31. Hjelmström, P., Penzotti, J.E., Henne, R.M. & Lybrand, T.P. (1998a), A molecular model of myelin oligodendrocyte glycoprotein. J. Neurochem., 71, 1742-1749.
32. Hjelmström, P., Juedes, A.E., Fjell, J. & Ruddle, N.H. (1998b), B cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol., 161, 4480-4483.
33. Ichikawa, M., Johns, T.G., Liu, J. & Bernard, C.C.A. (1996), Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J. Immunol., 157, 919-26.
34. Johns, T.G. & Bernard, C.C.A. (1997), Binding of complement component C1q to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation. Mol. Immunol., 34, 33-8.
35. Kahn, M.A. & De Vellis, J. (1994) Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia, 12: 87-98.
36. Kerlero de Rosbo, N., Honegger, P., Lassmann, H. & Matthieu, J.M. (1990), Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J. Neurochem., 55, 583-587.
37. Kitamura, D., Roes, J., Kühn, R. & Rajewsky, K. (1991), A B-cell deficient mouse by targeted disruption of the membrane exon of the immunoglobulin m chain gene. Nature, 350, 423-426.
38. Kojima, K., Berger, T., Lassmann, H., Hinze-Seich, D., Zhang, Y., Gehrmann, J., Reske, K., Wekerle, H. & Linington, C. (1994), Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100b molecule, a calcium binding protein of astroglia. J. Exp. Med., 180, 817-825.
39. Koni, P.A., Sacca, R., Lawton, P., Browning, J.L., Ruddle, N.H. & Flavell, R.A. (1997), Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity, 6, 491-500.
40. Kratz, A., Campos-Neto, A., Hanson, M.S. & Ruddle, N.H. (1996), Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med., 183, 1461-1472.
41. Körner, H., Riminton, D.S., Strickland, D.H., Lemckert, F.A., Pollard, J.D. & Sedgwick, J.D. (1997), Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med., 186, 1585-1590.
42. Krakowski, M. & Owens, T. (1996), Interferon-gamma confers resistance to experimental allergic encephalomyelitis allergic encephalomylitis. Eur. J. Immunol., 26, 1641-1646.
43. Kuchroo, V.K., Martin, C.A., Greer, J.M., Ju, S.-T., Sobel, R.A. & Dorf, M.A. (1993), Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol., 151, 4371-4382.
44. Lafaille, J.J., Keere, F.V., Hsu, A.L., Baron, J.L., Haas, W., Raine, C.S. & Tonegawa, S. (1997), Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med., 186, 307-312.
45. Lassmann, H., Brunner, C., Bradl, M. & Linington, C. (1988), Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol., 75, 566-576.
46. Liblau, R., Steinman, R. & Brocke, S. (1997), Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int. Immunol., 9, 799-803.
47. Linington, C. & Lassmann, H. (1987), Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J. Neuroimmunol., 17, 61-69.
48. Linington, C., Morgan, B.P., Scolding, N.J., Wilkins, P., Piddlesden, S. & Compston, D.A. (1989), The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain, 112, 895-911.
49. Linington, C., Engelhardt, B., Kapocs, G. & Lassman, H. (1992), Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J. Neuroimmunol., 40, 219-224.
50. Litzenburger, T., Fässler, R., Bauer, J., Lassmann, H., Linington, C., Wekerle, H. & Iglesias, A. (1998), B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med., 188, 169-180.
51. Liu, J., Marino, M.W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A.J., Old, L. & Bernard, C.C.A. (1998), TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med., 4, 78-83.
52. Malipiero, U., Frei, K., Spanaus, K.S., Agresti, C., Lassmann, H., Hahne, M., Tschopp, J., Eugster, H.P. & Fontana, A. (1997), Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perform knockout mice, but monophasic in Fas-and Fas ligand-deficient 1pr and gld mice. Eur. J. Immunol., 27, 3151-3160.
53. Mendel, I., Kerlero de Rosbo, N. & Ben-Nun, A. (1995), A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol., 25, 1951-1959.
54. Mendel, I., Katz, A., Kozak, N., Ben-Nun, A. & Revel, M. (1998), Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol., 28, 1727-1737.
55. Miller, D.J., Sanborn, K.S., Katzmann, J.A. & Rodriguez, M. (1994), Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J. Neurosci., 14, 6230-6238.
56. Myers, K.J., Sprent, J., Dougherty, J.P. & Ron, Y. (1992), Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol., 41, 1-8.
57. Okuda, Y., Sakoda, S., Bernard, C.C.A., Fujimura, H., Saeki, Y., Kishimoto, T. & Yanagihara, T. (1998a), IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelits provoked by myelin oligodendrocyte glycoprotein. Int. Immunol., 10, 703-708.
58. Okuda, Y., Sakoda, S., Bernard, C.C.A. & Yanagihara, T. (1998b), The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system. J. Interf. Cytokine Res., 18, 415-421.
59. Piddlesden, S.J., Lassmann, H., Zimprich, F., Morgan, B.P. & Linington, C. (1993), The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol., 143, 555-564.
60. Powell, M.B., Mitchell, D., Lederman, J., Buckmeier, J., Zamvil, S.S., Graham, M., Ruddle, N.H. & Steinman, L. (1990), Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol., 2, 539-544.
61. Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G. & Kollias, G. (1995), Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci., USA, 92, 11294-11298.
62. Raine, C.S. (1997), The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis, in "Multiple sclerosis: Clinical and pathogenic basis". (C.S. Raine, H.F. McFarland and W.W. Tourtellotte) (pp. 243-286) Chapman & Hall, London.
63. Riminton, D.S., Körner, H., Strickland, D.H., Lemckert, F.A., Pollard, J.D. & Sedgwick, J.D. (1998), Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med., 187, 1517-1528.
64. Romano, M., Sironi, M., Tontaiatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., Bussoluni, F., Poli, V., Ciliberto, G. & Mantovani, A. (1997), Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity, 6, 315-525.
65. Ruddle, N.H., Bergman, C.M., McGrath, K.M., Lingenheld, E.G., Grunnet, M.L., Padula, S.J. & Clark, R.B. (1990), An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med., 172, 1193-1200.
66. Ruddle, N.H. & Waksman, B.H. (1968), Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. III. Analysis of mechanism. J. Exp. Med., 128, 1267-1279.
67. Sahrbacher, U.C., Lechner, F., Eugster, H.-P., Frei, K., Lassmann, H. & Fontana, A. (1998), Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol., 28, 1332-1338.
68. Santambrogio, L., Hochwald, G.M., Saxena, B., Leu, C.H., Martz, J.E., Carlino, J.A., Ruddle, N.H., Palladino, M.A., Gold, L.I. & Thorbecke, G.J. (1993), Studies on the mechanisms by which TGF-β protects against allergic encephalomyelitis: antagonism between TGF-β and TNF. J. Immunol., 151, 1116-1127.
69. Schluesener, H.J., Sobel, R.A., Linington, C. & Weiner, H.L. (1987), A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol., 139, 4016-4021.
70. Selmaj, K., Raine, C.F., Farooq, M. & Brosnan, C.F. (1991a), Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol., 147, 1522-1529.
71. Selmaj, K., Raine, C.S. & Cross, A.H. (1991b), Antitumor necrosis factor theraphy abrogates autoimmune demyelination. Ann. Neurol., 30, 694-700.
72. Sheehan, K.C.F., Ruddle, N.H. & Schreiber, R.D. (1989) Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol., 142, 3884-3893.
73. Suen, W.E., Bergman, C.M., Hjelmstrom, P. & Ruddle, N.H. (1997), A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med., 186, 1233-1240.
74. Sun, J., Link, H., Olsson, T., Xiao, B.G., Andersson, G., Ekre, H.P., Linington, C. & Diener, P. (1991), T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol., 146, 1490-1495.
75. Taupin, V., Renno, T., Bourbonniere, L., Peterson, A.C., Rodriguez, M. & Owens, T. (1997), Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system. Eur. J. Immunol., 27, 905-913.
76. Willenborg, D.O. & Prowse, S.J. (1983) Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J. Neuroimmunol., 5, 99-109.
77. Willenborg, D.O., Fordham, S., Bernard, C.C.A., Cowden, W.B. & Ramshaw, I.A. (1996), IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyetis. J. Immunol., 157, 3223-3227.
78. Wolf, S.D., Dittel, B.N., Hardardottir, F. & Janeway, C.A. (1996), Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med., 184, 2271-2278.
79. Xiao, B.C., Linington, C. & Link, H. (1991), Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol., 31, 91-96.
80. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. & Tabira, T. (1997), Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med., 186, 1677-1687.
81. Zhao, M.-L. & Fritz, R.B. (1998), Acute and relapsing experimental autoimmune encephalomyelitis in IL-4 and α/β T cell-deficient C57BL/6 mice. J. Neuroimmunol., 87, 171-178.